Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Molecular Informatics|August 3, 2016
Exploiting Pharmacological Similarity to Identify Safety Concerns - Listen to What the Data Tells YouDaniel Muthas, Scott BoyerJournal of Molecular Graphics & Modelling|January 22, 2008
Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filteringDaniel Muthas, Yogesh A Sabnis, Magnus Lundborg, et al.Journal of Chemical Information and Modeling|October 15, 2011
DrugPred: a structure-based approach to predict protein druggability developed using an extensive nonredundant data setAgata Krasowski, Daniel Muthas, Aurijit Sarkar, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|December 14, 2011
Application of data mining and visualization techniques for the prediction of drug-induced nausea in manJoanna Parkinson, Daniel Muthas, Matthew Clark, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|June 15, 2007
Scope and limitations of Baird's theory on triplet state aromaticity: application to the tuning of singlet-triplet energy gaps in fulvenesHenrik Ottosson, Kristine Kilså, Khalil Chajara, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|February 4, 2010
Identification of small peptides mimicking the R2 C-terminus of Mycobacterium tuberculosis ribonucleotide reductaseDaniel J Ericsson, Johanna Nurbo, Daniel Muthas, et al.Toxicology and Applied Pharmacology|February 16, 2016
The value of integrating pre-clinical data to predict nausea and vomiting risk in humans as illustrated by AZD3514, a novel androgen receptor modulatorClaire Grant, Lorna Ewart, Daniel Muthas, et al.Bioorganic & Medicinal Chemistry|August 2, 2005
Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and IIDaniel Muthas, Daniel Nöteberg, Yogesh A Sabnis, et al.Bioorganic & Medicinal Chemistry Letters|June 30, 2009
Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitorsLuke R Odell, Mikael T Nilsson, Johan Gising, et al.Bioorganic & Medicinal Chemistry|February 12, 2013
Novel pseudopeptides incorporating a benzodiazepine-based turn mimetic--targeting Mycobacterium tuberculosis ribonucleotide reductaseJohanna Nurbo, Daniel J Ericsson, Ulrika Rosenström, et al.Pageof 4